O-159 A prospective randomized phase III, double-blind, placebo-controlled study of thalidomide in extended-disease (ED) SCLC patients after response to chemotherapy (CT)
Pujol, J., Breton, J., Gervais, R., Tanguy, M., Quoix, E., David, P., Janicot, H., Depierre, A., Gameroft, S., Geneve, J.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80293-4
Date:
July, 2005
File:
PDF, 276 KB
english, 2005